NRO Neurones SA

NEURONES: 5.1% organic growth in 2025

NEURONES: 5.1% organic growth in 2025

PRESS INFORMATION

Heading: 2025 annual revenues        Nanterre, February 11, 2026 (after trading)

5.1% organic growth in 2025

(being audited, in € millions)20242025Growthof which organic
4rd quarter revenues211.3225+ 6.5%+ 6.2%
Annual revenues810.4857.2+ 5.8%+ 5.1%

Achievements

NEURONES closes the financial year with annual revenue of €857.2 million, exceeding its expectations.

Growth is driven by digital and data projects (double-digit growth), while AI-related activities confirm a promising upward trend.

With its decentralized and responsive structure, the group took advantage of an environment that became more favorable at the end of the year.

Operating profit thus improved significantly, rising from 7.8% (in H1) to 9.8%* (in H2). For the full year, it stood at 8.8%*, exceeding the latest estimates.

To support this momentum, the average workforce grew by 280 people in 2025.

The full final annual results will be published on Wednesday, March 11, 2026, after the stock exchange closes.

Outlook

In a market that is expected to be more buoyant, forecasts for the current year will be announced, as usual, along with the Group's Q1 revenues.

* being audited.

About NEURONES

With close to 7,300 experts, and ranking among the French leaders in consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt AI and new uses.

Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible



Press Relations:

O'Connection

Julia Philippe-Brutin

Tel.: +33 (0)6 03 63 06 03









NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37



Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37





Attachment



EN
11/02/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE

NEURONES : Déclaration des transactions sur actions propres (période d...

NEURONES : Déclaration des transactions sur actions propres (période du 23 au 27 mars 2026) Nanterre, le 30 mars 2026 Déclaration des transactions sur actions propres(période du 23 au 27 mars 2026) Dans le cadre du programme de rachat d’actions propres autorisé par l’Assemblée Générale du 5 juin 2025 et confié au CIC, NEURONES a procédé, entre le 23 et le 27 mars 2026, aux achats suivants (code ISIN FR0004050250) : JourVolume total journalier(en nombre d'actions)Prix pondéré moyen(journalier unitaire)23/03/202646 39234,13 €24/03/202642 99333,47 €25/03/202611 66534,58 €26/03/20267 16634,2...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (March 23 to ...

NEURONES: Declaration of transactions on treasury shares (March 23 to 27, 2026) Nanterre, March 30, 2026 Declaration of transactions on treasury shares(period from 23 to 27 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 23 and 27, 2026 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)03/23/202646,39234.13 €03/24/202642,99333.47 €03/25/202611,66534.58 €03/26/20267,16634.26 €03/27/20266,80534.43 €Total115,021  As o...

 PRESS RELEASE

NEURONES : Déclaration des transactions sur actions propres (période d...

NEURONES : Déclaration des transactions sur actions propres (période du 16 au 20 mars 2026) Nanterre, le 23 mars 2026 Déclaration des transactions sur actions propres(période du 16 au 20 mars 2026) Dans le cadre du programme de rachat d’actions propres autorisé par l’Assemblée Générale du 5 juin 2025 et confié au CIC, NEURONES a procédé, entre le 16 et le 20 mars 2026, aux achats suivants (code ISIN FR0004050250) : JourVolume total journalier(en nombre d'actions)Prix pondéré moyen(journalier unitaire)16/03/202632 18634,17 €17/03/20266 80035,09 €18/03/20266 56735,05 €19/03/20266 38434,95 €...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (March 16 to ...

NEURONES: Declaration of transactions on treasury shares (March 16 to 20, 2026) Nanterre, March 23, 2026 Declaration of transactions on treasury shares(period from 16 to 20 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 16 and 20, 2026 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)03/16/202632,186€34.1703/17/20266,800€35.0903/18/20266,567€35,0503/19/20266,384€34,9503/20/202621,011€34,16Total72,948  As of March...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (March 9 to 1...

NEURONES: Declaration of transactions on treasury shares (March 9 to 13, 2026) Nanterre, March 16, 2026 Declaration of transactions on treasury shares(period from 9 to 13 March 2026) As part of the share buyback program authorized by the General Meeting of June 5, 2025 and entrusted to CIC, NEURONES made the following purchases between March 9 and 13, 2026 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)03/12/202625,669€36.1003/13/20266,734€34.96Total32,403  As of March 13, 2026, excluding the liquidity contract, NEURONES now holds 42,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch